SmileDirectClub, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US83192H1068
USD
0.00
0 (-100.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

79.25 k

Shareholding (Dec 2023)

FII

4.39%

Held by 49 FIIs

DII

87.62%

Held by 11 DIIs

Promoter

0.00%

How big is SmileDirectClub, Inc.?

22-Jun-2025

As of Jun 18, SmileDirectClub, Inc. has a market capitalization of 0.00, classifying it as a Micro Cap, with net sales of 414.88 million and a net profit of -258.69 million over the latest four quarters. The company reported shareholder's funds of 111.40 million and total assets of 597.06 million as of Dec 22.

Market Cap: As of Jun 18, SmileDirectClub, Inc. has a market capitalization of 0.00, classifying it as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, SmileDirectClub, Inc. reported net sales of 414.88 million and a net profit of -258.69 million.<BR><BR>Balance Sheet Snapshot: As of Dec 22, the company reported shareholder's funds of 111.40 million and total assets of 597.06 million.

Read More

Who are in the management team of SmileDirectClub, Inc.?

22-Jun-2025

As of March 2022, the management team of SmileDirectClub, Inc. includes CEO David Katzman, co-founders Alexander and Jordan Katzman, COO Steven Katzman, and several directors including Susan Rammelt, William Frist, Carol Hamilton, Richard Schnall, and Richard Wallman. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of SmileDirectClub, Inc. includes the following individuals:<BR><BR>- Mr. David Katzman: Chairman of the Board, Chief Executive Officer<BR>- Mr. Alexander Fenkell: Co-Founder, Director<BR>- Mr. Jordan Katzman: Co-Founder, Director<BR>- Mr. Steven Katzman: Chief Operating Officer, Director<BR>- Ms. Susan Rammelt: Chief Legal Officer, Executive Vice President- Business, General Counsel, Secretary, Director<BR>- Dr. William Frist: Director<BR>- Ms. Carol Hamilton: Director<BR>- Mr. Richard Schnall: Director<BR>- Mr. Richard Wallman: Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Read More

Is SmileDirectClub, Inc. overvalued or undervalued?

20-Sep-2025

As of July 8, 2024, SmileDirectClub, Inc. has deteriorated to a "does not qualify" valuation grade, is overvalued with a P/E ratio of -0.0002 and an ROE of -273.42%, and has experienced a total loss of value over the past several years, contrasting sharply with positive returns from the S&P 500.

As of 8 July 2024, the valuation grade for SmileDirectClub, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company is overvalued, as evidenced by its P/E ratio of -0.0002, EV to EBIT of -3.87, and a troubling ROE of -273.42%. Comparatively, peers like Modular Medical, Inc. and Check-Cap Ltd. have P/E ratios of -1.8607 and -0.2464, respectively, highlighting that SmileDirectClub is underperforming relative to its industry.<BR><BR>The company's stock has experienced a complete loss of value, with returns of -100% over the past week, month, year, and even over three to ten years, starkly contrasting with the S&P 500's positive returns during the same periods. This further reinforces the notion that SmileDirectClub is not only overvalued but also struggling to maintain any semblance of market viability.

Read More

Is SmileDirectClub, Inc. technically bullish or bearish?

20-Sep-2025

As of December 26, 2023, SmileDirectClub, Inc. shows a mildly bearish trend, with bearish weekly MACD, mildly bullish monthly MACD, and significant weakness reflected in a -100% return compared to the S&P 500's positive returns.

As of 26 December 2023, the technical trend for SmileDirectClub, Inc. has changed from bearish to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance. The RSI indicates a bearish condition on the monthly timeframe, with no trend on the weekly. Moving averages are mildly bearish on the daily timeframe. Overall, the stock is experiencing significant weakness, with returns of -100% over multiple periods compared to the S&P 500, which has positive returns of 12.22% YTD and 17.14% over the past year. The current technical stance is mildly bearish.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

9.72

stock-summary
Return on Equity

-273.42%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
102 Million
(Quarterly Results - Jun 2023)
Net Profit:
-54 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
-100.0%
0%
-100.0%
2 Years
-100.0%
0%
-100.0%
3 Years
-100.0%
0%
-100.0%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%

SmileDirectClub, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.94%
EBIT Growth (5y)
-244.72%
EBIT to Interest (avg)
-14.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
9.72
Sales to Capital Employed (avg)
0.61
Tax Ratio
0.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.40%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
-3.87
EV to EBITDA
-5.60
EV to Capital Employed
0.91
EV to Sales
2.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-23.45%
ROE (Latest)
-273.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 15 Schemes (7.99%)

Foreign Institutions

Held by 49 Foreign Institutions (4.39%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2023 is -19.08% vs -27.78% in Jun 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2023 is 17.86% vs -18.44% in Jun 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Jun'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "101.80",
          "val2": "125.80",
          "chgp": "-19.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-21.00",
          "val2": "-32.40",
          "chgp": "35.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.50",
          "val2": "4.50",
          "chgp": "88.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.50",
          "val2": "-3.00",
          "chgp": "-183.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-53.80",
          "val2": "-65.50",
          "chgp": "17.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-358.40%",
          "val2": "-413.20%",
          "chgp": "5.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is -26.18% vs -2.92% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 17.19% vs -20.50% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "470.70",
          "val2": "637.60",
          "chgp": "-26.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-166.80",
          "val2": "-183.90",
          "chgp": "9.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.00",
          "val2": "23.20",
          "chgp": "-22.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-21.00",
          "val2": "-52.90",
          "chgp": "60.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-277.90",
          "val2": "-335.60",
          "chgp": "17.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-512.30%",
          "val2": "-398.40%",
          "chgp": "-11.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'23 - YoYstock-summary
Jun'23
Jun'22
Change(%)
Net Sales
101.80
125.80
-19.08%
Operating Profit (PBDIT) excl Other Income
-21.00
-32.40
35.19%
Interest
8.50
4.50
88.89%
Exceptional Items
-8.50
-3.00
-183.33%
Consolidate Net Profit
-53.80
-65.50
17.86%
Operating Profit Margin (Excl OI)
-358.40%
-413.20%
5.48%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2023 is -19.08% vs -27.78% in Jun 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2023 is 17.86% vs -18.44% in Jun 2022

Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
470.70
637.60
-26.18%
Operating Profit (PBDIT) excl Other Income
-166.80
-183.90
9.30%
Interest
18.00
23.20
-22.41%
Exceptional Items
-21.00
-52.90
60.30%
Consolidate Net Profit
-277.90
-335.60
17.19%
Operating Profit Margin (Excl OI)
-512.30%
-398.40%
-11.39%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is -26.18% vs -2.92% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 17.19% vs -20.50% in Dec 2021

stock-summaryCompany CV
About SmileDirectClub, Inc. stock-summary
stock-summary
SmileDirectClub, Inc.
Pharmaceuticals & Biotechnology
SmileDirectClub, Inc. provides medical technology platform. The Company provides SmileCheck, which is a teledentistry platform for doctor monitoring and communication. The Company provides clear aligner therapy treatment through its teledentistry platform. Its aligner treatment addresses the orthodontics market. The Company has a network of approximately 240 orthodontists and general dentists across the United States, Puerto Rico, Canada, Australia and the United Kingdom. The Company provides customer care to its members through a variety of communication channels, including its Website, phone, chat, e-mail and social media. SmileCheck platform is a central data repository for all medical records, business transactions and member communications. SmileCheck provides online portal that allows for remote access to treatment plan information. The Company offers aligners, impression kits, whitening gel and retainers.
Company Coordinates stock-summary
Company Details
414 Union St , NASHVILLE TN : 37219-1757
Registrar Details